These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16670630)

  • 1. High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome.
    Einama T; Kagata Y; Tsuda H; Morita D; Ogata S; Ueda S; Takigawa T; Kawarabayashi N; Fukatsu K; Sugiura Y; Matsubara O; Hatsuse K
    Pancreas; 2006 May; 32(4):376-81. PubMed ID: 16670630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
    Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.
    Einama T; Kamachi H; Nishihara H; Homma S; Kanno H; Takahashi K; Sasaki A; Tahara M; Okada K; Muraoka S; Kamiyama T; Matsuno Y; Ozaki M; Todo S
    Pancreas; 2011 Nov; 40(8):1276-82. PubMed ID: 21775916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors.
    Li JQ; Wu F; Masaki T; Kubo A; Fujita J; Dixon DA; Beauchamp RD; Ishida T; Kuriyama S; Imaida K
    Int J Oncol; 2004 Jul; 25(1):87-95. PubMed ID: 15201993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
    Hu YQ; Liu YJ
    Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival.
    Huang HY; Huang WW; Wu JM; Huang CK; Wang JW; Eng HL; Lin CN; Chou SC; Yu SC; Fang FM; Lee JC; Li CF
    Ann Surg Oncol; 2008 Aug; 15(8):2239-49. PubMed ID: 18516647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
    Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
    Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of skp2 expression in primary breast cancer.
    Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
    Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
    Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
    Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer.
    Masugi Y; Yamazaki K; Hibi T; Aiura K; Kitagawa Y; Sakamoto M
    Hum Pathol; 2010 Aug; 41(8):1061-8. PubMed ID: 20413143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K; Supriatno ; Kawaguchi S; Kawashima Y; Itashiki Y; Yoshida H; Sato M
    Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients.
    Fang FM; Chien CY; Li CF; Shiu WY; Chen CH; Huang HY
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):202-7. PubMed ID: 18538504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.